GlassScriptPhysician profile
Jesse A Lipnick
NPI 1992784284
$37,983.92
in general payments reported to CMS, 2019-2025
39 companies · $1,649 in 2025
The $1,649 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,937 · 2020: $4,364 · 2021: $6,316 · 2022: $4,991 · 2023: $6,382 · 2024: $8,345 · 2025: $1,649.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,599 · Travel and Lodging: $6,777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,599.10 |
| Travel and Lodging | $6,776.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,788.13 | 2021-2025 | Synchromedii, Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| Vertos Medical, INC. | $5,190.78 | 2019-2023 | Mild Device Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $3,591.11 | 2019-2020 | |
| Boston Scientific Corporation | $3,156.73 | 2019-2025 | Intracept, General - Pain Management, Wavewriter Alpha Prime 16 |
| Medtronic USA, INC. | $2,393.88 | 2019-2020 | |
| Nevro Corp. | $2,130.26 | 2019-2024 | Senza |
| Spinal Simplicity, LLC | $2,061.24 | 2024-2025 | Ha Minuteman G3-R |
| Stryker Corporation | $1,896.24 | 2022-2024 | Spinejack, Augment Injectable |
| Si-Bone, INC. | $1,720.86 | 2024-2025 | |
| Painteq LLC | $1,576.72 | 2022-2024 | Painteq |
| Abbott Laboratories | $1,289.67 | 2019-2024 | Proclaim |
| Nalu Medical, INC. | $874.11 | 2021-2023 | Nalu Neurostimulation System |
| Foundation Fusion Solutions, LLC | $688.85 | 2023-2024 | |
| Abbvie INC. | $360.04 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $248.95 | 2022 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Lipnick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.